Recruiting at 5 sites No phase Heart Failure With Reduced Ejection Fraction

Heart Failure With Reduced Ejection Fraction study: EPIC-HF Patient-facing Tool

Official title Implementation and Interaction of Clinician And Patient-facing Tools Aiming to Intensify Neurohormonal Medicines for Heart Failure

ClinicalTrials.gov ID: NCT06526988

What this study is testing

What it's testing
This study is testing whether a video and checklist for patients and electronic alerts for doctors can help people with heart failure get better medicine doses.
Who it's for
You may be able to join if you have heart failure with reduced ejection fraction and see a doctor at one of the five hospitals.
What's involved
You will receive a short video and a checklist before your clinic visit, and your doctor may get alerts in their computer to adjust your medicines. You will keep doing your regular visits.
Time commitment
The study lasts about a year, with your usual clinic visits and a few extra check‑ins to see how the tools work.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older

You may be able to join if

  • Clinician (MD, PA, NP) who practices in cardiology outpatient clinics
  • Age \> 18 years
  • LVEF \</=40% on most recent cardiology imaging study
  • Has a new or return clinic visit with an enrolled clinician within the next 7 days
  • Is missing at least one of the four classes of medications and does not have an allergy to that class: (1) beta blockers, (2) angiotensin...

You likely can't join if

  • Has a left ventricular assist device
  • Under evaluation for or listed for transplant (or s/p transplant)
  • Glomerular filtration rate (GFR) less than 20 or on dialysis
  • On hospice care
  • Preferred language neither English or Spanish

The study team makes the final eligibility decision.

Where it is enrolling

  • Walnut Creek, California, United States
  • Aurora, Colorado, United States
  • New Haven, Connecticut, United States
  • Chicago, Illinois, United States
  • Salt Lake City, Utah, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

This study is enrolling now at Walnut Creek, California, United States; Aurora, Colorado, United States; New Haven, Connecticut, United States; Chicago, Illinois, United States; Salt Lake City, Utah, United States. Enter your location above to see the nearest enrolling site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.